|
2023
|
Invention
|
Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma.
The invention relates to histone d... |
|
2022
|
Invention
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-lig... |
|
|
Invention
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhib... |
|
|
Invention
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a cd38 inhibitor and m... |
|
|
Invention
|
Increasing expression of interferon regulated genes with combinatons of histone deacetylase inhib... |
|
2019
|
Invention
|
Combinations of histone deacetylase inhibitors and immunomodulatory drugs.
The invention relates... |
|
|
Invention
|
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof. The present... |
|
|
Invention
|
Phenyl and pyridinyl hydroxamic acids. The present invention relates to pyrimidine hydroxy amide ... |
|
2017
|
Invention
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a bcl-2 inhibitor and ... |
|
|
Invention
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and epothilone and methods... |
|
|
Invention
|
Pharmaceutical combinations of histone deacetylase 6 inhibitors and cd20 inhibitory antibodies an... |
|
|
Invention
|
Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and cd20 inhibit... |
|
|
Invention
|
Methods of use and pharmaceutical combinations of hdac inhibitors with bet inhibitors. The disclo... |
|
|
Invention
|
Biomarkers to identify patients that will respond to treatment and treating such patients. The in... |
|
|
Invention
|
Hdac inhibitors, alone or in combination with btk inhibitors, for treating chronic lymphocytic le... |
|
|
Invention
|
Increasing expression of interferon regulated genes with combinations of histone deacetylase inhi... |
|
2016
|
Invention
|
Hdac inhibitors for the treatment of diabetic peripheral neuropathy. The invention relates to HDA... |
|
|
Invention
|
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof.
The presen... |
|
|
Invention
|
Pyrimidine hydroxy amide compounds as hdac6 selective inhibitors. The present invention relates t... |
|
|
Invention
|
Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof. ... |
|
|
Invention
|
Combinations of histone deacetylase inhibitors and either her2 inhibitors or pi3k inhibitors. The... |
|
|
Invention
|
Crystalline forms of a histone deacetylase inhibitor. This disclosure provides solid forms of 2-(... |
|
|
Invention
|
Methods of making protein deacetylase inhibitors. The present invention relates to methods and in... |
|
|
Invention
|
Treatment of neuroblastoma with histone deacetylase inhibotrs. Provided herein are combinations c... |
|
|
Invention
|
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors.
Provided herein are compou... |
|
2015
|
Invention
|
Piperidine derivatives as hdac1/2 inhibitors. Provided herein are compounds, pharmaceutical compo... |
|
|
Invention
|
Pyrimidine hydroxy amide compounds for treating peripheral neuropathy. The invention relates to H... |
|
|
Invention
|
Induction of gata2 by hdac1 and hdac2 inhibitors. Provided herein are compounds, pharmaceutical c... |
|
|
Invention
|
Treatment of leukemia with histone deacetylase inhibitors. Provided herein are combinations compr... |
|
2014
|
Invention
|
Treatment of diseases caused by abnormal lymphocyte function with an hdac6 inhibitor.
An HDAC6 i... |
